When the COVID-19 pandemic shut down New York City in March 2020, Jose Montanez, like millions of others in the service industry, lost his source of income. A hair stylist who also ran karaoke drag shows, he made his money ...
Dec 8, 2021
0
6
(HealthDay)—In 2019, infant mortality reached a historic low in the United States, with a rate of 5.58 infant deaths per 1,000 live births, according to the Dec. 8 National Vital Statistics Reports, a publication from ...
Dec 8, 2021
0
12
New research from the University of East Anglia and Quadram Institute reveals how our immune cells use the body's fat stores to fight infection.
Dec 8, 2021
0
250
Emerging viruses can adversely affect women's health, leading to an increase in both complications and deaths during pregnancy, childbirth and the puerperium. This is indicated by a population-based natural experiment on ...
Nov 29, 2021
0
4
(HealthDay)—Among women with three or more good-quality blastocysts, conventional in-vitro fertilization (IVF) results in a cumulative live-birth rate that is noninferior to the rate obtained using embryo selection with ...
Nov 29, 2021
0
1
A global target for the elimination of mother to child transmission of HIV globally was set in 2015. The ambitious target of the Joint United Nations Programme (UNAIDS) was to reduce new infant HIV infections by 75 percent ...
Nov 29, 2021
0
15
A strong, universal, responsive civil registration and vital statistics (CRVS) system is critical for Asia Pacific countries to recover from the COVID-19 pandemic and ensure that the most vulnerable have access to healthcare, ...
Nov 24, 2021
0
1
Physiotherapist David Putrino was working on a vibrating glove to help deaf people experience live music when a friend mentioned that the same technology might stop tremors in people with Parkinson's disease.
Nov 22, 2021
0
12
Previous research has found that chemotherapy can trigger muscle loss in people living with cancer, but a new study out of Penn State found it may also affect the way the body builds new muscle—and at lower doses than previously ...
Nov 22, 2021
0
3
Pharmaceutical giant AstraZeneca on Thursday announced that clinical trials of an antibody-based COVID-19 drug had shown robust efficacy and long-term prevention.
Nov 18, 2021
0
56
